Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a rise in the availability of various types of test kits in APAC, growing awareness and importance of early detection, and implementation of mass testing programs by governments.
The test kits market in APAC is segmented as below:
By End-user
- Government
- Non-government
By Type
- Rapid test kit
- RT-PCR
- Others
The report on the test kits market in APAC covers the following areas:
- Test kits market in APAC sizing
- Test kits market in APAC forecast
- Test kits market in APAC industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the test kits market in APAC: 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, altona Diagnostics GmbH, BGI Group, Bio Rad Laboratories Inc., CAMTECH DIAGNOSTICS, Co Diagnostics Inc., Danaher Corp., Denka Co. Ltd., Edinburgh Genetics Ltd., F. Hoffmann La Roche Ltd., Genes2Me Pvt. Ltd., Guangzhou Wondfo Biotech Co. Ltd., Hologic Inc., JN Medsys Pte. Ltd., KogeneBiotech, Kurabo Industries Ltd., Maccura Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt Ltd., QIAGEN NV, Sd Biosensor Inc., Seegene Inc., SolGent Co. Ltd., Sysmex Corp., Tata Sons Pvt. Ltd., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advancements in technology to develop rapid and accurate test kits.'
According to the report, one of the major drivers for this market is the rise in availability of various types of test kits in APAC.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3D Biomedicine Science and Technology Co. Ltd.
- Abbott Laboratories
- altona Diagnostics GmbH
- BGI Group
- Bio Rad Laboratories Inc.
- CAMTECH DIAGNOSTICS
- Co Diagnostics Inc.
- Danaher Corp.
- Denka Co. Ltd.
- Edinburgh Genetics Ltd.
- F. Hoffmann La Roche Ltd.
- Genes2Me Pvt. Ltd.
- Guangzhou Wondfo Biotech Co. Ltd.
- Hologic Inc.
- JN Medsys Pte. Ltd.
- KogeneBiotech
- Kurabo Industries Ltd.
- Maccura Biotechnology Co. Ltd.
- Mylab Discovery Solutions Pvt Ltd.
- QIAGEN NV
- Sd Biosensor Inc.
- Seegene Inc.
- SolGent Co. Ltd.
- Sysmex Corp.
- Tata Sons Pvt. Ltd.
- Thermo Fisher Scientific Inc.